International Biotechnology Trust plc
Share this pagePrint this page

Portfolio Analysis

31 August 2016

Summary

 

IBT Portfolio NAV (m)

217

Number of Portfolio Companies

82

Quoted Investments

58

Unquoted Investments

24

 

NAV % Quoted / Unquoted Split
NAV % by Geography

Quoted

90%

United States / Canada

78%

Unquoted

10%

Europe

22%

Total

100% 

Total

100%

 

 

 

 

 

NAV % by Therapeutic Areas
NAV % by Market Cap

 

 

Oncology

34%

Large Cap >USD10BN

72%

Orphan

22%

Mid Cap =USD1-10BN

5%

CNS

10%

Small Cap < USD1BN

23%

Ophtalmology

9%

 

 

Inflammation

8%

 

 

Medtech

1%

 

 

Other

16%

 

 

Total100%